Drug Discovery World

JULY 12, 2023

Hosted by DDW and sponsored by Elegen, “Where are the breakthroughs in mRNA drug discovery and development?” Join this free webinar to learn about the opportunities in mRNA drug discovery and development. An audience Q&A session with the presenters will follow the webinar presentation.

DNA 130

DNA Drugs Engineering Drug Development 130

Drug Discovery World

AUGUST 23, 2023

In vitro ADME and drug-drug interaction (DDI) investigations are early activities in the drug development process that are critical for framing downstream decision making. This webinar will provide insights at a high-level related to regulatory drivers, investigatory objectives, and practical concerns for such studies.

Drug Development 130

Drug Development Drugs 130

Drug Discovery World

AUGUST 16, 2023

In vitro ADME and drug-drug interaction (DDI) investigations are early activities in the drug development process that are critical for framing downstream decision making. This webinar will provide insights at a high-level related to regulatory drivers, investigatory objectives, and practical concerns for such studies.

Drug Development 130

Drug Development Drugs 130

Drug Discovery World

NOVEMBER 15, 2022

Many of the most promising areas of drug development in this field target neuroinflammation and remyelination. In this new on-demand webinar we use multiple sclerosis as a case-study of a neurodegenerative disease, so you can: Understand the key processes in neurodegeneration. Watch the webinar now.

Drugs 130

Drugs Science Drug Development Disease 130

Drug Discovery World

JUNE 21, 2023

Hosted by DDW and sponsored by Elegen, “Where are the breakthroughs in mRNA drug discovery and development?” Join this free webinar to learn about the opportunities in mRNA drug discovery and development. An audience Q&A session with the presenters will follow the webinar presentation.

DNA 130

DNA Drugs Engineering Drug Development 130

Drug Discovery World

AUGUST 9, 2023

In vitro ADME and drug-drug interaction (DDI) investigations are early activities in the drug development process that are critical for framing downstream decision making. This webinar will provide insights at a high-level related to regulatory drivers, investigatory objectives, and practical concerns for such studies.

Drug Development 130

Drug Development Drugs 130

Drug Discovery World

APRIL 24, 2023

Join this free webinar to learn about the biggest challenges and opportunities facing the next-generation sequencing (NGS) oncology space. The post Free webinar today: How is NGS informing oncology drug discovery? appeared first on Drug Discovery World (DDW). Register now.

RNA 130

RNA Medical Schools Clinical Trials Drugs 130

Drug Discovery World

APRIL 11, 2023

Join this free webinar to learn about the biggest challenges and opportunities facing the next-generation sequencing (NGS) oncology space. The post Webinar: Find out how NGS is informing oncology drug discovery appeared first on Drug Discovery World (DDW). Register now.

RNA 130

RNA Medical Schools Clinical Trials Drugs 130

Fierce BioTech

JUNE 14, 2024

How AI Accelerates Clinical & Drug Development Timelines pesurya Fri, 06/14/2024 - 10:59 Wed, 09/11/2024 - 14:00 Resource Type Webinar Viswa Colluru, Ph.D. What Lies Ahead Speakers will discuss future opportunities to expand the application of AI in both clinical and drug development and where the industry is trending.

Drug Development 52

Drug Development Clinical Research Drugs Research 52

Fierce BioTech

MAY 21, 2024

png Listing Introduction Join us for an webinar on Revolutionizing Drug Development: AI Innovations in Healthcare, where you'll learn about the latest advancements in leveraging artificial intelligence to transform the drug development process. Listing Image AlphaSense_ListingLogo_250x190.png

Drug Development 52

Drug Development Clinical Trials Drugs Trials 52

Drug Discovery World

SEPTEMBER 26, 2023

In this webinar you will discover how iPSC derived cells can be used to advance the efficiency and efficacy of disease modelling. ‘ Discover how iPSC derived cells can be used to support the development of drug and gene therapies’ will take place on 28 September 4PM BST, 5PM CEST, EDT 11AM, PDT 8AM.

Drug Development 130

Drug Development Disease Drugs Treatment 130

Drug Discovery World

SEPTEMBER 5, 2023

In this webinar you will discover how iPSC derived cells can be used to advance the efficiency and efficacy of disease modelling. ‘ Discover how iPSC derived cells can be used to support the development of drug and gene therapies’ will take place on 28 September 4PM BST, 5PM CEST, EDT 11AM, PDT 8AM.

Drug Development 147

Drug Development Disease Drugs Treatment 147

Drug Discovery World

FEBRUARY 23, 2023

Mari Goldsmith, Application Scientist at Torx Software and John Kratunis, Manager, Customer Success Specialists, NA at CAS will demonstrate the power of combining Torx with CAS SciFinder n to ensure the correct decisions are made quickly to deliver new drugs faster. Register for free here.

Small Molecule 130

Small Molecule Drugs Research Drug Development 130

Alta Sciences

AUGUST 18, 2023

Webinar— A Square Peg in a Round Hole–Navigating the Unique Attributes of Psychedelic Drug Development iianiro Fri, 08/18/2023 - 19:49 URL [link] Description Save the date—Join us for a complimentary webinar for an overview of the draft FDA guidance on early-phase clinical development of psychedelics and how Altasciences can guide you through the process, (..)

Drug Development 40

Drug Development Compliance Clinical Development FDA 40

Fierce BioTech

APRIL 3, 2024

Mini-Organs, Major Breakthroughs: How Hub Organoids Are Accelerating Oncology Drug Development dwunderlin Wed, 04/03/2024 - 17:28 Tue, 05/14/2024 - 09:30 Resource Type Webinar Dr. Sylvia F. Boj Duration 60 Minutes Patient-derived organoids are viewed as the gold standard in bridging the gap between the lab and the clinic.

Drug Development 52

Drug Development Drugs Therapies Treatment 52

Collaborative Drug

AUGUST 1, 2023

Streamlining Collaborations and Drug Development using CDD Vault and ELN

Drug Development 68

Drug Development Drugs 68

Alta Sciences

FEBRUARY 8, 2024

In this on-demand webinar, Ingrid Holmes , Vice President of Global Clinical Operations at Altasciences, and Dr. Gary G. Various psychomotor and neuropsychological tests, including the measurement of reaction time, divided attention, selective attention, and memory, may still be appropriate.

Clinical Trials 52

Clinical Trials Trials Clinical Pharmacology Clinical Development 52

Perficient: Drug Development

SEPTEMBER 15, 2023

Through a headless approach, it addresses recurring ecommerce needs, speeds up development processes, and enhances existing projects. Register Now We’re thrilled about this upcoming webinar and hope you are too! With visually appealing design and customizable components, it amplifies user experiences.

105

105

Perficient: Drug Development

FEBRUARY 13, 2024

Learn about Adobe’s commitment to maintaining HIPAA-ready standards within commerce solutions and join Perficient and Adobe for a webinar hosted by CMSWire. EST Secure Digital Conversion: Unveiling Adobe’s HIPAA-Ready Commerce Solution webinar hosted by CMSWire. Register Today! Thursday, February 22 at 12:00 P.M.

Pharmacy 52

Pharmacy Regulations Science Marketing 52

Drug Discovery World

AUGUST 9, 2023

In vitro ADME and drug-drug interaction (DDI) investigations are early activities in the drug development process that are critical for framing downstream decision making. This webinar will provide insights at a high-level related to regulatory drivers, investigatory objectives, and practical concerns for such studies.

Drugs 130

Drugs Drug Development 130

Alta Sciences

APRIL 17, 2024

Five Promising Treatment Areas in Early-Phase Drug Development in 2024 aasimakopoulos Wed, 04/17/2024 - 15:52 Early-phase drug development is an ever-changing landscape, as emerging science leads to new promising areas of research for the treatment of human health issues.

Drug Development 52

Drug Development Treatment FDA Approval Therapies 52

Drug Discovery World

JUNE 12, 2024

This unique combination bridges the gap between the lab and the clinic, enabling the development of more effective therapies. The webinar will feature Dr Sylvia F Boj, Chief Scientific Officer of HUB Organoids.

Laboratories 130

Laboratories Disease Regulations Drug Development 130

Drug Discovery World

JANUARY 25, 2023

Join this free webinar , hosted by DDW and supported by BPS Bioscience and Benchling, to learn about the biggest challenges and opportunities facing the cell and gene therapy sector. autologous therapies/solid tumours/ indications outside of oncology?)     The webinar will take place on February 17, 2023 4PM GMT. 

Therapies 130

Therapies Drug Development Marketing Disease 130

Drug Discovery World

MAY 22, 2024

This unique combination bridges the gap between the lab and the clinic, enabling the development of more effective therapies. The webinar will feature Dr Sylvia F Boj, Chief Scientific Officer of HUB Organoids.

Laboratories 147

Laboratories Disease Regulations Drug Development 147

Drug Discovery World

JUNE 5, 2024

This unique combination bridges the gap between the lab and the clinic, enabling the development of more effective therapies. The webinar will feature Dr Sylvia F Boj, Chief Scientific Officer of HUB Organoids.

Laboratories 130

Laboratories Disease Regulations Drug Development 130

Drug Discovery World

MAY 29, 2024

This unique combination bridges the gap between the lab and the clinic, enabling the development of more effective therapies. The webinar will feature Dr Sylvia F Boj, Chief Scientific Officer of HUB Organoids.

Drugs 130

Drugs Laboratories Disease Regulations 130

Alta Sciences

JUNE 9, 2023

Accelerating Global Drug Development Timelines With Ethnobridging rmaloney Mon, 06/12/2023 - 16:07 HTML Safe Strategy to Save Time and Money Avoid repeating Phase I studies for drugs intended for the Asian market. Download your copy today. In this complimentary webinar , Mel B. Watch the webinar.

Drug Development 40

Drug Development Clinical Trials Biosimilars Pharmacokinetics 40

Drug Discovery World

AUGUST 30, 2023

In vitro ADME and drug-drug interaction (DDI) investigations are early activities in the drug development process that are critical for framing downstream decision making. This webinar will provide insights at a high-level related to regulatory drivers, investigatory objectives, and practical concerns for such studies.

Drug Development 130

Drug Development Drugs 130

Alta Sciences

JANUARY 22, 2024

Get a Head Start On Your 2024 Preclinical Drug Development Program blussier Mon, 01/22/2024 - 15:18 HTML EXPERTISE Matters. With four strategically placed preclinical research facilities throughout North America, Altasciences can get your CTA/IND-enabling studies underway in just 8 weeks!

Drug Development 40

Drug Development Clinical Trials Drugs Trials 40

Perficient: Drug Development

SEPTEMBER 1, 2023

Register for this free webinar here We understand how to get the most out of Optimizely’s diverse digital experience platform to create highly effective and personalized experiences for our customers.

52

52

Drug Discovery World

JULY 5, 2023

Hosted by DDW and sponsored by Elegen, “Where are the breakthroughs in mRNA drug discovery and development?” Join this free webinar to learn about the opportunities in mRNA drug discovery and development. An audience Q&A session with the presenters will follow the webinar presentation.

DNA 130

DNA Engineering Drug Development Disease 130

Drug Discovery World

JUNE 28, 2023

Hosted by DDW and sponsored by Elegen, “Where are the breakthroughs in mRNA drug discovery and development?” Join this free webinar to learn about the opportunities in mRNA drug discovery and development. An audience Q&A session with the presenters will follow the webinar presentation.

DNA 130

DNA Drugs Engineering Drug Development 130

Drug Discovery World

OCTOBER 12, 2023

Join this free webinar to learn about innovation taking place in the neuroscience field. You will hear from Fiona Elwood, VP, Disease Area Stronghold Lead, Neurodegeneration, Janssen, and Jenny Barnett, CEO of Monument TX, as well as Rosanna Zhang, Vice President of Corporate Development at ACROBiosystems. Register free here.

Disease 130

Disease Science Drug Development Drugs 130

LifeSciVC

FEBRUARY 27, 2024

By Ivana Magovčević-Liebisch, CEO of Vigil Neuroscience, as part of the From The Trenches feature of LifeSciVC Patients and their care partners are at the center of our work in the life sciences industry – but at what point during the drug development process should companies start to engage these key stakeholders?

Drug Development 63

Drug Development Disease Drugs Treatment 63

Drug Discovery World

JANUARY 25, 2023

In this free webinar on February 17, 2023 you will hear from CBO/CDO of Adthera Bio, Stuart Curbishley, Chief Executive Officer of Cell & Gene Therapy Catapult, Matthew Durdy, Founder and CEO of Dark Horse Consulting, Anthony Davies, and Scientific Solutions Consultant at Benchling, Brian Fan.

Therapies 130

Therapies Drug Development Marketing Disease 130

Conversations in Drug Development Trends

JUNE 13, 2024

At Worldwide, Matt Cooper and Jim Eamma , our Executive Directors, Therapeutic Strategy Leads in Oncology, shed light on the intricacies of modern oncology trials in their recent webinar, “ Navigating the Landscape of Complex & Adaptive Oncology Trials.”

Trials 52

Trials Clinical Trials Clinical Development Drug Development 52

Drug Discovery World

APRIL 18, 2023

Join this free webinar to learn about the biggest challenges and opportunities facing the next-generation sequencing (NGS) oncology space. Can NGS increase the chances of an oncology drug making it to market? Can NGS identify previously undruggable targets in cancer?

RNA 130

RNA Medical Schools Clinical Trials Drugs 130